Columbia University

What Columbia University does

Columbia University is a private, nonprofit Ivy League research university founded in 1754 and headquartered in New York City. It operates across multiple campuses including Morningside Heights (main undergraduate campus), Manhattanville, the Columbia University Irving Medical Center (CUIMC), and the Lamont-Doherty Earth Observatory, with Columbia Global Centers in ten international cities. The university delivers academic programs across three undergraduate schools and fifteen graduate and professional schools (Columbia College, Fu Foundation School of Engineering, Business, Law, Journalism, Vagelos College of Physicians and Surgeons, Mailman School of Public Health, Climate School, etc.), serving more than 40,000 students, faculty, and staff annually, with undergraduates from families earning under $150,000 attending tuition-free.

Columbia's core "products" are educational credentials (degrees conferred to ~18,000 graduates in 2026), research output (over $1 billion in annual federal research funding, 400+ inventions annually managed by Columbia Technology Ventures), and clinical care delivered through CUIMC and ColumbiaDoctors. Its underlying research infrastructure includes the Zuckerman Institute (neuroscience), Data Science Institute, Irving Institute for Clinical and Translational Research, Columbia Quantum Initiative, Climate School, and 25 libraries supporting 200+ research centers. The institution generates technology transfer revenue through licensing arrangements with companies such as Silo Pharma, Made Scientific, and Revolution Medicines.

Columbia's revenue model is diversified across tuition and fees (with extensive financial aid subsidy), federal research grants (NIH, NSF, DOD, HHS exceeding $1 billion annually), clinical services through CUIMC, endowment income and philanthropy (including a $400 million Vagelos gift commitment and $11.5 million from the Bezos Earth Fund), and technology licensing royalties. Its total annual economic activity in New York State is reported at $12.6 billion, with $3.8 billion in annual faculty and staff compensation, positioning it as the 11th largest private-sector employer in the New York area.

Name

Columbia University

Legal name

Columbia University in the City of New York

Website

https://columbia.edu

Company type

Private

Founded year

1754

Operating status

Operating

Headcount range

11–50 employees

Short description

Columbia University is a private Ivy League research university in New York City founded in 1754, operating 18 schools across multiple campuses and serving over 40,000 students, faculty, and staff with academic programs, $1B+ in annual research funding, and clinical care through its Irving Medical Center.

Ownership category

akta.pro rank

Product category

Higher Education

NAICS

Colleges, Universities, and Professional Schools (6113), Colleges, Universities, and Professional Schools (611310), Colleges, Universities, and Professional Schools (61131)

SIC

Services-Educational Services (8200), Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Comprehensive Doctoral Research Universities (Multi-Disciplinary) (EDAHABAA)

Keywords

• Higher education
• Research university
• Medical education
• Graduate programs
• Technology licensing

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices9 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

1. Tuition and Fees: Columbia generates substantial revenue from tuition and fees across its undergraduate and graduate professional schools. Columbia College and Engineering undergraduates from families with annual incomes less than $150,000 and typical assets attend tuition-free, supported by institutional financial aid.
2. Federal Research Grants: Columbia receives over $1 billion annually in federal research funding from agencies including NIH, NSF, and Department of Defense. The university regained $400 million in federal grants in 2025 following a settlement with the Trump administration over antisemitism concerns. Columbia's Irving Institute secured a $75 million CTSA grant from NIH.
3. Healthcare Services (CUIMC): Columbia University Irving Medical Center generates clinical revenue through patient care services across the Vagelos College of Physicians and Surgeons, College of Dental Medicine, and School of Nursing.
4. Endowment and Philanthropy: Columbia's endowment supports operations and financial aid. The university received a $400 million gift commitment from Roy and Diana Vagelos for biomedical research. A $221 million settlement was paid to the federal government, with $200 million in fines and $21 million for EEOC settlements.
5. Technology Transfer and Licensing: Columbia Technology Ventures manages technology transfer. Columbia holds patents licensed to companies including Silo Pharma (PTSD treatment) and Made Scientific (NOVAKnee implant). Columbia received approximately $11.5 million from the Bezos Earth Fund for sustainable textiles research.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels9 records

Core offering

Columbia University is a private Ivy League research university that delivers undergraduate, graduate, and professional education across 18 schools and colleges, conducts federally and industry-funded research exceeding $1 billion annually, and operates a major academic medical center (CUIMC) providing clinical care, while licensing inventions and managing a global endowment through its technology ventures office.

Product overview

Columbia University is a major academic institution offering undergraduate, graduate, and professional education across multiple schools including Columbia College, Engineering, Business, Law, Medicine, and Climate School. The university operates research centers and institutes conducting scientific research with over $1 billion in annual research funding. Columbia's product portfolio consists of educational programs (academic degree offerings), research services (discovery and innovation), and specialized institutes like the Zuckerman Institute for brain science and the Irving Medical Center for health sciences. The institution does not offer commercial software products but rather educational and research services.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Over $12.6 billion in annual economic activity generated in New York State, including nearly 1% of NYC's economic output
• +4 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

14 partnerships are on record, tiered major, core and minor.

• HIVE Digital TechnologiesmajorStrategic or Co-development Partner · 22 June 2026Columbia's Department of Industrial Engineering and Operations Research collaborated with HIVE Digital Technologies on an inaugural AI research project demonstrating that HIVE's A40 GPUs in Asunción, Paraguay could match H100 performance after code optimization. The research was submitted to the NeurIPS machine learning conference, establishing proof of concept for intercontinental AI training over 5,000 miles.
• University of Illinois Urbana-Champaign and IARPAcoreStrategic or Co-development Partner · 10 June 2026Researchers from University of Illinois Urbana-Champaign and Columbia University, funded by IARPA (Intelligence Advanced Research Projects Activity), are leading the CEDAR project to reduce hallucinations in large language models, focusing on uncertainty quantification, knowledge updating, memory augmentation, and System 2 thinking.
• MIT and NASA (NEOWISE)coreStrategic or Co-development Partner · 8 June 2026Columbia University astronomers collaborated with MIT and NASA to detect the earliest known flickering quasar from just 850 million years after the Big Bang using data from NASA's NEOWISE infrared telescope mission.
• Revolution MedicinescoreStrategic or Co-development Partner · 3 June 2026Columbia University provided research support for daraxonrasib, a RAS(ON) multi-selective inhibitor developed by Revolution Medicines, which nearly doubled overall survival in pancreatic cancer patients in the phase 3 RASolute 302 trial, published in the New England Journal of Medicine.
• Pershing Square Sohn Cancer Research AlliancecoreStrategic or Co-development Partner · 7 May 2026The Pershing Square Sohn Cancer Research Alliance awarded $58 million to 90 scientists at 24 institutions over 13 years, supporting Columbia researchers in cancer research including immunotherapy, AI-driven protein design, and novel drug development. In 2026, 13 innovators each received $750,000 through the expanded national program.
• Locksley Resources LimitedcoreStrategic or Co-development Partner · 29 April 2026Research collaboration with Locksley Resources Limited to advance processing pathways for rare earth elements at the Mojave Project in California. Led by Professor Greeshma Gadikota at Columbia's Department of Earth and Environmental Engineering, focused on recovery, separation, and metallization of rare earth elements from carbonatite and bastnasite-style mineral systems.
• Made ScientificcoreOEM/ Whitelabel/ Licensing Partner · 29 April 2026Made Scientific was selected to manufacture the NOVAKnee biologic total knee replacement implant developed by Columbia researchers, a biodegradable scaffold seeded with progenitor cells for biological knee tissue regeneration. Phase I clinical trials are planned to begin in the US in 2028.
• FC Bayern MunichcoreStrategic or Co-development Partner · 23 April 2026FC Bayern Munich and Columbia University celebrated the 10th anniversary of their sports management education partnership, which has engaged more than 1,000 students through guest lectures, bespoke case studies, and direct access to FC Bayern's business operations. The club has provided more than 20 internship positions for Columbia students.
• NYCEDC and Gotham FoundryminorStrategic or Co-development Partner · 22 April 2026Columbia University partnered with NYCEDC and Gotham Foundry on the Advanced Materials Pitch Competition, awarding $25,000 total ($20,000 from NYCEDC Impact Award plus $5,000 from Columbia University) to four early-stage companies developing sustainable solutions in fashion, construction, food, and healthcare sectors.
• U.S. Critical Materials Corp.majorStrategic or Co-development Partner · 16 April 2026Columbia University signed a two-year 'Mud to Metal' research agreement with U.S. Critical Materials Corp. to develop technologies for recovering gallium, scandium, titanium, and rare earth elements from red mud (bauxite residue). Led by Professor Greeshma Gadikota, the research addresses U.S. reliance on imports for defense-critical metals essential for semiconductors, aerospace, and advanced weapons systems.
• Faraday FutureminorStrategic or Co-development Partner · 9 April 2026Faraday Future showcased its latest sustainable innovations and electric vehicle prototypes at the 2026 Columbia Global Sustainability Summit held at Columbia University, with presentations on sustainable materials, autonomous driving systems, and emissions reduction.
• Google DeepMind, Microsoft Research, and t54 LabscoreStrategic or Co-development Partner · 8 April 2026Columbia University researchers collaborated with Google DeepMind, Microsoft Research, and t54 Labs to publish a paper proposing the Agentic Risk Standard (ARS), an open-source framework applying financial risk management principles to AI agent transactions to protect users from financial losses.
• Silo PharmacoreOEM/ Whitelabel/ Licensing Partner · 7 April 2026Silo Pharma holds an exclusive license from Columbia University for SPC-15, a serotonin 4 (5-HT4) receptor agonist for preventing stress-induced fear and depressive-like behavior. The European Patent Office indicated intent to grant the patent in April 2026, with Columbia receiving patent royalties.
• Amazon Web Services (AWS)coreStrategic or Co-development Partner · 7 November 2025AWS and Columbia co-hosted the Columbia X Amazon Bedrock Innovation Challenge on November 7, 2025, bringing together 173 students in 47 teams to develop AI-powered prototype applications using Amazon Bedrock's generative AI and agentic capabilities. Three winning teams each received $5,000 in AWS credits.

Scale indicators17 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Harvard University: Harvard is the closest Ivy League peer to Columbia: a private research university in the Northeast with comparable scale (~$50B endowment, 40,000+ population), top-tier medical center, $1B+ annual research funding, and direct competition for students, faculty, and federal grants.
• Stanford University: Stanford is a private research university with comparable scale, a major medical center, and similarly strong tech transfer output, competing with Columbia for federal grants, faculty, and AI/biotech leadership.
• Yale University: Yale is a fellow Ivy League private research university with overlapping graduate/professional schools, similar endowment scale, comparable research funding, and a major medical center, competing head-to-head with Columbia for applicants and faculty.
• Brown University: Brown is an Ivy League peer with comparable scale, selectivity, and research profile. Less overlap in medical/engineering but a direct competitor for undergraduate applicants and federal research funding.
• University of Pennsylvania: UPenn is an Ivy League peer with a major academic medical center (Penn Medicine), comparable research funding, similar scale of professional schools, and direct overlap with Columbia in Wharton/Columbia Business School competition.
• Cornell University: Cornell is an Ivy League peer with comparable research enterprise, federal funding, and tech transfer activity (including the joint Alopecia Areata patent work referenced in Columbia's portfolio). Competes in NYC-adjacent applicant markets.
• Princeton University: Princeton is a private Ivy League research university with similar selectivity, comparable research enterprise, and shared applicant pool. Lacks a medical center, so a slightly narrower peer but a direct competitor in undergraduate and graduate STEM.
• Massachusetts Institute of Technology: MIT is a direct peer in private research-intensive higher education with comparable $1B+ research funding, leadership in STEM/AI/engineering, and active technology transfer. Columbia and MIT have also collaborated on joint research (e.g., AI protein language model with Harvard).

Broad incumbents

• University of Chicago: University of Chicago is a leading private research university with comparable research funding, top-tier business school, and similar scale of graduate programs. A peer in research-intensive private higher education though not Ivy League.

Regional players

• New York University: NYU is the most direct NYC-based private research university competitor to Columbia. It shares the Manhattan talent market, has comparable professional schools (Law, Medicine, Business), and competes for the same student demographics. Regional overlap is highest of any peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/columbia
• YouTubeyoutube.com/user/columbiauniversity
• Facebookfacebook.com/columbia
• LinkedInlinkedin.com/company/columbia-university
• Instagraminstagram.com/columbia

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries12 records

Funding overview

Funding rounds10 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments6 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Columbia University